These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34450647)

  • 1. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.
    Kho MML; Reinders MEJ; Baan CC; van Baarle D; Bemelman FJ; Diavatopoulos DA; Gansevoort RT; van der Klis FRM; Koopmans MPG; Messchendorp AL; van der Molen RG; Remmerswaal EBM; Rots N; Vart P; de Vries RD; Hilbrands LB; Sanders JF;
    Nephrol Dial Transplant; 2021 Aug; 36(9):1761-1764. PubMed ID: 34450647
    [No Abstract]   [Full Text] [Related]  

  • 2. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
    Sanders JF; Bemelman FJ; Messchendorp AL; Baan CC; van Baarle D; van Binnendijk R; Diavatopoulos DA; Frölke SC; Geers D; GeurtsvanKessel CH; den Hartog G; van der Heiden M; Imhof C; Kho MML; Koopmans MPG; Malahe SRK; Mattheussens WB; van der Molen R; van Mourik D; Remmerswaal EBM; Rots N; Vart P; de Vries RD; Gansevoort RT; Hilbrands LB; Reinders MEJ;
    Transplantation; 2022 Apr; 106(4):821-834. PubMed ID: 34753894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SARS-CoV-2 vaccines - what the nephrologist should know].
    Heine GH; Becker SL; Scheuer AL; Schirmer SH
    Dtsch Med Wochenschr; 2021 Apr; 146(7):466-470. PubMed ID: 33780993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?
    Chirumbolo S
    J Med Virol; 2021 Jul; 93(7):4049-4053. PubMed ID: 33666240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology.
    Wijewickrama ES; Abdul Hafidz MI; Robinson BM; Johnson DW; Liew A; Dreyer G; Caskey FJ; Bello AK; Zaidi D; Damster S; Salaro S; Luyckx VA; Bajpai D
    BMJ Open; 2022 Dec; 12(12):e065112. PubMed ID: 36585149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintaining Safety with SARS-CoV-2 Vaccines.
    Castells MC; Phillips EJ
    N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
    Sanders JF; Messchendorp AL; de Vries RD; Baan CC; van Baarle D; van Binnendijk R; Diavatopoulos DA; Geers D; Schmitz KS; GeurtsvanKessel CH; den Hartog G; Kho MML; Koopmans MPG; van der Molen RG; Remmerswaal EBM; Rots N; Gansevoort RT; Bemelman FJ; Hilbrands LB; Reinders MEJ;
    Clin Infect Dis; 2023 Feb; 76(3):e188-e199. PubMed ID: 35796536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
    Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M
    Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of mRNA-Based Vaccines for SARS CoV-2.
    Barda B; Cerny A
    Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients.
    Longlune N; Nogier MB; Miedougé M; Gabilan C; Cartou C; Seigneuric B; Del Bello A; Marion O; Faguer S; Izopet J; Kamar N
    Nephrol Dial Transplant; 2021 Aug; 36(9):1704-1709. PubMed ID: 34057463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
    Transpl Int; 2021; 35():10026. PubMed ID: 35185359
    [No Abstract]   [Full Text] [Related]  

  • 16. mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
    Wijtvliet VPWM; Ariën KK; Abrams S; Couttenye MM; Mestrez F; Mariën J; De Winter BY; Van Damme P; Pipeleers L; Wissing KM; Abramowicz D; Ledeganck KJ
    Nephrol Dial Transplant; 2022 Mar; 37(4):799-803. PubMed ID: 34888697
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
    Quiroga B; Soler MJ; Ortiz A; Martínez Vaquera S; Jarava Mantecón CJ; Useche G; Sánchez Márquez MG; Carnerero M; Jaldo Rodríguez MT; Muñoz Ramos P; Ruiz San Millán JC; Toapanta N; Gracia-Iguacel C; Aguilar Cervera MC; Balibrea Lara N; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
    Nephrol Dial Transplant; 2022 Sep; 37(10):1868-1878. PubMed ID: 34788858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
    Kho MML; Messchendorp AL; Frölke SC; Imhof C; Koomen VJ; Malahe SRK; Vart P; Geers D; de Vries RD; GeurtsvanKessel CH; Baan CC; van der Molen RG; Diavatopoulos DA; Remmerswaal EBM; van Baarle D; van Binnendijk R; den Hartog G; de Vries APJ; Gansevoort RT; Bemelman FJ; Reinders MEJ; Sanders JF; Hilbrands LB;
    Lancet Infect Dis; 2023 Mar; 23(3):307-319. PubMed ID: 36354032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.
    Piotrowska M; Zieliński M; Tylicki L; Biedunkiewicz B; Kubanek A; Ślizień Z; Polewska K; Tylicki P; Muchlado M; Sakowska J; Renke M; Sudoł A; Dąbrowska M; Lichodziejewska-Niemierko M; Smiatacz T; Dębska-Ślizień A; Trzonkowski P
    Front Immunol; 2022; 13():832924. PubMed ID: 35935974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.
    Bloomfield M; Parackova Z; Hanzlikova J; Lastovicka J; Sediva A
    J Clin Immunol; 2022 Feb; 42(2):266-269. PubMed ID: 34718945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.